Ritonavir, used for the treatment of HIV infection and viral hepatitis C, received the marketing authorization certificate and became the first drug in the...
«Pharmaceutical industry can and should be financially self-sufficient,» said Peter Bely, Chairman of the Board of Directors of Promomed Group at the «Strategy Implementation...
A plenary session where Denis Manturov, Minister of Industry and Trade, and Mikhail Murashko, Minister of Health, participated focused on the issue of “Future...
On September 30, with the support of Biokhimik JSC of Promomed Group, the scientific and educational laboratory for the synthesis of active pharmaceutical substances...
Petrovax Pharm LLC has received a European patent for the original medicine product Longidaza®, which is valid in the UK, Germany, France, Switzerland, Ireland,...
R-Pharm Group, the Russian Direct Investment Fund (RDIF) and AstraZeneca announce preliminary virus neutralizing activity results of combined use of the AstraZeneca vaccine (developed...